To read more: 💪 <a href=" The ketogenic diet is definitely the new superstar in the health and weight loss world. It can be ...

A five-year study on a low-carbohydrate, remote care intervention for type 2 diabetes shows significant improvements in ...

Objective Sodium–glucose cotransporter 2 (SGLT-2) inhibitors are the most recently approved antihyperglycemic medications. We sought to describe their association with euglycemic diabetic ...

The low-carb, high-fat ketogenic diet has been promoted online and in the media as a weight-loss tool and seemingly all-round magical healer. Yet it was first developed in the 1920s for children ...

Ketogenic Diet May Reduce Friendly Gut Bacteria and ... have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease. Now, a team of researchers ...

Oct. 24, 2024 — Obesity is a common cause of diabetes, heart disease and early death, but risk differs greatly from one person to the next. A pioneering clinical risk prediction algorithm has ...

NEW YORK, Oct. 22 (UPI) --A low-carbohydrate diet may help adults with type 2 diabetes gain better blood sugar control and make it possible to decrease diabetes medication, a new study suggests.

Type 2 diabetes can be reversed for at least two years using a weight management diet, a study has found. More than a third of people with the condition who spent up to five months on a strict ...

People with type 2 diabetes who stick to a low-carb diet may be able to stop taking medication, suggests a new study. American researchers found low-carbohydrate diets may improve beta-cell ...

BOURNEMOUTH, England : A third sending-off in eight games proved too much for Mikel Arteta's Arsenal as they fell to their first defeat of the season, losing 2-0 away to Bournemouth to leave the ...

As many as 3.2 million people in the UK are prediabetic according to Diabetes UK; that is, they are at risk of developing Type 2 diabetes (T2D) due to higher than normal blood glucose levels.

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.